Calithera biosciences, inc. (CALA)
CashFlow / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14
Cash Flows Used in Operating Activities
Net loss

-90,619

-89,860

-87,631

-86,187

-65,110

-54,629

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net loss

-

-

-

-

-

-

-

-

-

-

-

-

-34,009

-

-36,552

-36,908

-34,368

-32,644

-31,409

-27,748

-25,421

-21,712

0

0

0

Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation

459

479

496

507

506

505

486

449

409

365

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Amortization of premiums on investments

772

897

878

721

518

272

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Depreciation and amortization

-

-

-

-

-

-

-

-

-

-

-

-

-

-

306

328

380

404

424

434

397

361

0

0

0

Amortization of premiums on investments

-

-

-

-

-

-

-

-

-

-

-

0

494

-

663

677

619

446

0

0

0

-

-

-

-

Stock-based compensation

6,776

6,466

6,828

7,114

7,239

7,437

7,185

6,834

6,268

5,536

5,031

4,639

4,372

4,250

4,199

4,002

3,704

3,272

2,574

1,862

1,206

689

0

0

0

Loss on disposal of property and equipment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

7

0

0

0

-

-

-

-

Non-cash lease expense

1,399

1,366

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Changes in operating assets and liabilities:
Receivables from collaborations

-1,537

-1,515

-97

-771

689

855

-368

208

-11,726

1,142

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Prepaid expenses and other current assets

36

26

114

215

-1,105

-630

-2,664

-367

1,161

952

2,601

-96

-541

-787

-180

249

618

673

398

202

1,055

1,544

0

0

0

Other assets

-74

-289

-484

-354

230

341

87

313

273

-62

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Accounts payable

-867

816

204

229

-552

175

-656

620

1,586

674

36

-900

-336

-28

700

523

491

-131

-222

37

385

543

0

0

0

Accrued liabilities

-1,567

2,576

6,374

7,103

4,820

4,725

2,953

4,542

6,393

4,878

3,633

1,602

790

925

-1,666

79

256

-196

2,944

1,189

1,883

2,058

0

0

0

Lease liability

1,520

1,469

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenue

-

-

-

-

-

-22,254

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenue

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Deferred rent, non-current

-

-

-

-

-

37

413

514

584

656

0

0

0

-

-

-

-112

-

-94

-42

271

372

0

0

0

Net cash used in operating activities

-85,136

-78,745

-74,238

-71,124

-70,514

-64,842

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cash Flows (Used in) Provided by Investing Activities
Net cash provided by (used in) operating activities

-

-

-

-

-

-

-

-

-

-

-

-

11,832

-

-32,166

-31,554

-29,910

-29,933

-24,490

-23,755

-22,338

-19,231

0

0

0

Purchases of investments

196,182

153,227

156,795

85,788

73,379

76,107

67,585

89,731

117,467

194,650

183,164

166,826

126,147

44,618

56,064

51,602

101,179

109,099

0

0

0

-

-

-

-

Proceeds from sale and maturity of investments

175,808

142,450

126,300

106,750

114,194

129,120

144,369

143,209

118,374

97,448

70,133

69,063

63,749

68,724

0

0

0

-

-

-

-

-

-

-

-

Purchases of property and equipment

0

-

-

-

-

214

731

1,064

1,205

1,229

846

417

286

401

338

367

542

441

410

659

560

556

0

0

0

Net cash (used in) provided by investing activities

-20,394

-10,784

-30,533

20,810

40,627

52,799

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cash Flows Provided by Financing Activities
Net cash provided by (used in) investing activities

-

-

-

-

-

-

-

-

-

-

-

-

-62,684

-

27,780

22,829

-36,882

-66,776

-74,134

-77,680

-20,896

-486

0

0

0

Proceeds from issuance of common stock upon public offering, net

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from issuance of common stock under stock purchase agreement, net

-

-

-

-

-

-

-

-

-

7,914

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from issuance of common stock through an at-the-market offering, net

50,177

43,926

0

0

0

-

-

-

-

38,315

41,227

44,217

43,963

11,281

0

0

0

-

-

-

-

-

-

-

-

Proceeds from stock option exercises

0

-

-

-

0

-

-

-

0

-

-

-

0

-

-

-

0

-

-

-

0

-

-

-

0

Net cash provided by financing activities

105,413

98,908

65,297

71,236

15,630

14,626

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash provided by financing activities

-

-

-

-

-

-

-

-

-

-

-

-

128,152

-

7,555

4,732

5,081

845

72,203

85,004

87,856

87,866

0

0

0

Net decrease in cash, cash equivalents, and restricted cash

-117

9,379

-39,474

20,922

-14,257

2,583

21,724

-2,127

-34,231

38,268

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Supplemental Disclosure of Non-Cash Financing Information:
Net increase (decrease) in cash and cash equivalents

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3,169

-3,993

-61,711

-95,864

-26,421

-16,431

44,622

68,149

0

0

0

Supplemental Disclosure of Non-Cash Activities:
Unpaid amounts related to stock issuance and deferred financing costs

0

-

-

0

0

-

-

0

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

Unpaid amounts related to property and equipment purchases

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-